Long-term remission of recurren pityriasis versicolor with short-term systemic isotretinoin therapy
- Journal of Dermatology & Cosmetology
-
Serkan Yazici, Emel Bulbul Baskan, Hayriye Saricaoglu
Department of Dermatology and Venereology, Uludag University School of Medicine, Turkey - Emel Bulbul Baskan, Department of Dermatology and Venereology, Uludag University School of Medicine, Turkey
- Hayriye Saricaoglu, Department of Dermatology and Venereology, Uludag University School of Medicine, Turkey
Abstract
Although Pityriasis versicolor (PV) well responds to medical therapy, recurrence is a common problem and management of recurrent and chronic PV is a challange. ?sotretinoin (13-cis retinoic acid) is a vitamin A derivative, decreases sebaceous gland size and sebum production up to 90%. Although the efficiency of isotretinoin is well known in acne and acne-related disorders, literature regarding its use in PV is scarce. We present here a 33 year-old man succesfully treated and achieved long-term remission with oral isotretinoin therapy who was suffering from diffuse, recurrent PV for nearly 15 years. We believe that low-dose and short-term isotretinoin may be a good therapeutic option for recurrent and chronic PV.
Keywords
malassezia genus, topical retinoic acids, hidradenitis suppurativa, sebaceous gland atrophy, acne, drug use, seborrheic dermatitis, colonization, saprophytic, fungal infection, isotretinoin, therapy, long-term remission, pityriasis versicolor, recurrence